Orexigen Therapeutics Inc (OTC Pink - No Information:OREXQ)

0.145
Delayed Data
As of 2:12pm ET
 -0.01 / -6.45%
Today’s Change
0.09
Today|||52-Week Range
3.22
-88.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-24.6M-69.1M-30.5M-20.8M
 
 
 
 
 
Depreciation2.0M2.1M2.1M2.1M
 
 
 
 
 
Total Other Cash Flow-10.8M14.8M-7.3M1.7M
 
 
 
 
 
Funds From Operations-33.4M-52.2M-35.7M-17.0M
 
 
 
 
 
Funds From/For Other Operating Expenses323.0K-2.2M4.4M-722.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-33.7M-49.9M-40.1M-16.3M
 
 
 
 
 
 
InvestingIncrease In Investments75.0M0.00-90.0M0.00
 
 
 
Decrease In Investments-10.0M1.5M140.0M25.0M
 
 
 
 
 
Capital Expenditures-44.0K0.000.000.00
 
 
Net Assets From Acquisitions -63.5M-3.4M0.000.00
 
 
 
Net Cash Flow Investing61.9M-1.9M50.0M25.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-10.0M-14.0M0.00-301.0K
 
 
 
 
Net Proceeds Stock Sale49.0K0.0047.0K391.0K
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-9.9M-14.0M47.0K90.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-189.0K-14.0K44.0K105.0K
 
 
 
 
 
 
Net Change In Cash18.3M-65.8M10.0M8.8M